These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1519036)

  • 1. Involvement of interleukin-2 and interferon-gamma in the immune response induced by influenza virus iscoms.
    Villacres-Eriksson M; Bergström-Mollaoglu M; Kåberg H; Morein B
    Scand J Immunol; 1992 Sep; 36(3):421-6. PubMed ID: 1519036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics, localization and cytokine profile of T cell responses to immune stimulating complexes (iscoms) containing human influenza virus envelope glycoproteins.
    Sjölander A; Bengtsson KL; Morein B
    Vaccine; 1997 Jun; 15(9):1030-8. PubMed ID: 9261953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The induction of cell-associated and secreted IL-1 by iscoms, matrix or micelles in murine splenic cells.
    Villacres-Eriksson M; Bergström-Mollaoglu M; Kåberg H; Lövgren K; Morein B
    Clin Exp Immunol; 1993 Jul; 93(1):120-5. PubMed ID: 8324897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen presentation by naive macrophages, dendritic cells and B cells to primed T lymphocytes and their cytokine production following exposure to immunostimulating complexes.
    Villacres-Eriksson M
    Clin Exp Immunol; 1995 Oct; 102(1):46-52. PubMed ID: 7554398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMS.
    Maloy KJ; Donachie AM; Mowat AM
    Eur J Immunol; 1995 Oct; 25(10):2835-41. PubMed ID: 7589080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of IL-2 and IFN-gamma in BALB/c mice immunised with subunit influenza A vaccine in combination with whole cell or acellular DTP vaccine.
    Tamizifar H; Jennings R; Ali SA; Potter CW
    J Med Microbiol; 1997 Jan; 46(1):61-6. PubMed ID: 9003747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Quillaja saponaria triterpenoid content on the immunomodulatory capacity of Epstein-Barr virus iscoms.
    Dotsika E; Karagouni E; Sundquist B; Morein B; Morgan A; Villacres-Eriksson M
    Scand J Immunol; 1997 Mar; 45(3):261-8. PubMed ID: 9122615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cocaine administration to influenza virus-immunized mice on cytokine profiles of individual splenic CD4+ and CD8+ T cells.
    Di Francesco P; Falchetti R; Gaziano R; Lanzilli G; Casalinuovo IA; Ravagnan G; Garaci E
    Clin Exp Immunol; 1999 Dec; 118(3):428-34. PubMed ID: 10594563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses in mice induced by HSV-1 glycoproteins presented with ISCOMs or NISV delivery systems.
    Hassan Y; Brewer JM; Alexander J; Jennings R
    Vaccine; 1996 Dec; 14(17-18):1581-9. PubMed ID: 9032885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody responses, cytokine levels and protection of mice immunised with HSV-2 antigens formulated into NISV or ISCOM delivery systems.
    Mohamedi SA; Brewer JM; Alexander J; Heath AW; Jennings R
    Vaccine; 2000 Apr; 18(20):2083-94. PubMed ID: 10715522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics, localization and isotype profile of antibody responses to immune stimulating complexes (iscoms) containing human influenza virus envelope glycoproteins.
    Sjölander A; Lövgren Bengtsson K; Johansson M; Morein B
    Scand J Immunol; 1996 Feb; 43(2):164-72. PubMed ID: 8633196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses.
    Hu KF; Elvander M; Merza M; Akerblom L; Brandenburg A; Morein B
    Clin Exp Immunol; 1998 Aug; 113(2):235-43. PubMed ID: 9717973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of ISCOMs for immunization against hepatitis B.
    Pandey RS; Dixit VK
    Curr Pharm Biotechnol; 2009 Nov; 10(7):709-16. PubMed ID: 19751176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internalization of iscom-borne antigens and presentation under MHC class I or class II restriction.
    Villacres MC; Behboudi S; Nikkila T; Lovgren-Bengtsson K; Morein B
    Cell Immunol; 1998 Apr; 185(1):30-8. PubMed ID: 9636680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulation by Quillaja saponaria adjuvant formulations: in vivo stimulation of interleukin 12 and its effects on the antibody response.
    Villacres-Eriksson M; Behboudi S; Morgan AJ; Trinchieri G; Morein B
    Cytokine; 1997 Feb; 9(2):73-82. PubMed ID: 9071557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenic CD4+ and CD8+ T cells from influenza immune mice concurrently produce in vitro IL2, IL4, and IFN-gamma.
    Falchetti R; Lanzilli G; Casalinuovo IA; Gaziano R; Palamara AT; Di Francesco P; Ravagnan G; Garaci E
    Cell Immunol; 1996 Jun; 170(2):222-9. PubMed ID: 8660821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugation of synthetic peptides to carrier iscoms: factors affecting the immunogenicity of the conjugate.
    Lövgren K; Larsson M
    J Immunol Methods; 1994 Aug; 173(2):237-43. PubMed ID: 7519222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of iscoms and their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses: comparison of spleen cells from mice inoculated with iscoms and/or matrix.
    Fossum C; Bergström M; Lövgren K; Watson DL; Morein B
    Cell Immunol; 1990 Sep; 129(2):414-25. PubMed ID: 2383899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of systemic and mucosal immune responses following immunization with somatostatin-avidin complexes incorporated into ISCOMS.
    Estrada A; Laarveld B; Li B; Redmond MJ
    Immunol Invest; 1995 Aug; 24(5):819-28. PubMed ID: 8543345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
    Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A
    Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.